Le Lézard
Classified in: Science and technology
Subjects: Conference, Contract/Agreement, Product/Service, Trade Show

ExtraHop® Announces Integration with CrowdStrike Falcon® Next-Gen SIEM


ExtraHop®, a leader in cloud-native network detection and response (NDR), today announced an integration with CrowdStrike Falcon® Next-Gen SIEM, empowering joint customers to stop threats faster by utilizing network telemetry directly in the AI-native CrowdStrike Falcon platform.

Attackers are increasingly evolving their tactics to evade traditional security controls, hiding in encrypted east-west network traffic, using living off the land techniques, and exploiting devices that organizations can't put an endpoint agent on. To better identify these threats, security teams rely on multiple sources of data for complete ??visibility across their entire environment.

RevealXtm, the NDR platform from ExtraHop, ingests, monitors, and automatically analyzes network data, giving enterprises immediate visibility into all of their east-west and north-south network traffic ? even encrypted communications. Integrating RevealX with Falcon Next-Gen SIEM unifies that deep network telemetry with rich security data, threat intelligence, AI and workflow automation from the CrowdStrike Falcon platform to give joint customers more reliable, relevant, and contextual security alerts.

With the latest CrowdStrike and ExtraHop integration, customers benefit from:

"The needs of the modern SOC have outgrown the capabilities of the legacy SIEM. The explosion of data sources and arduous data ingestion processes combined with the inability to correlate disparate sources and automate orchestrated responses, leaves security teams behind adversaries," said Daniel Bernard, Chief Business Officer, CrowdStrike. "Today's security teams need a reimagined SIEM that combines an AI-powered platform approach with critical network data sources, such as ExtraHop, to stop breaches with speed and accuracy."

"NDR is essential to a successful next gen SIEM deployment and ExtraHop is best suited to help organizations reap the benefits of network data in security operations through expanded attack surface visibility, superior threat detection, and faster incident investigation and response," said Kanaiya Vasani, Chief Product Officer, ExtraHop. "As a market leader, we recognize the power of integrating our award-winning technology into the CrowdStrike Falcon Next Gen SIEM, and, together, our ability to give customers faster access to the information they need to manage and mitigate their cyber risk."

Visit booth #N-6245 at RSA Conference to demo the integration today.

Additional Resources

About ExtraHop®

ExtraHop is the cybersecurity partner enterprises trust to reveal cyber risk and build business resilience. The ExtraHop RevealXtm network detection and response (NDR) platform uniquely delivers the unparalleled visibility and decryption capabilities that organizations need to investigate smarter, stop threats faster, and move at the speed of risk. Learn more at www.extrahop.com.

© 2024 ExtraHop Networks, Inc., RevealX, RevealX 360, RevealX Enterprise, and ExtraHop are registered trademarks or trademarks of ExtraHop Networks, Inc.


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: